Zimmer Biomet Holdings, Inc. (ZBH)
USD 105.86
(-2.04%)
USD 105.86
(-2.04%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 5.31 Billion USD | -5.23% |
| 2022 | 4.92 Billion USD | 1.1% |
| 2021 | 4.86 Billion USD | -0.6% |
| 2020 | 4.89 Billion USD | -14.55% |
| 2019 | 5.72 Billion USD | 1.21% |
| 2018 | 5.66 Billion USD | -0.53% |
| 2017 | 5.69 Billion USD | 7.2% |
| 2016 | 5.3 Billion USD | 28.2% |
| 2015 | 4.14 Billion USD | 20.96% |
| 2014 | 3.42 Billion USD | 2.58% |
| 2013 | 3.33 Billion USD | -0.27% |
| 2012 | 3.34 Billion USD | 0.5% |
| 2011 | 3.32 Billion USD | 3.8% |
| 2010 | 3.2 Billion USD | 3.32% |
| 2009 | 3.1 Billion USD | -0.61% |
| 2008 | 3.12 Billion USD | 3.38% |
| 2007 | 3.02 Billion USD | 11.28% |
| 2006 | 2.71 Billion USD | 6.62% |
| 2005 | 2.54 Billion USD | 15.71% |
| 2004 | 2.2 Billion USD | 58.94% |
| 2003 | 1.38 Billion USD | 34.76% |
| 2002 | 1.02 Billion USD | 20.51% |
| 2001 | 852.7 Million USD | 13.74% |
| 2000 | 749.7 Million USD | 11.9% |
| 1999 | 670 Million USD | 12.42% |
| 1998 | 596 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 1.17 Billion USD | 0.79% |
| 2024 Q3 | 1.28 Billion USD | 9.08% |
| 2024 Q1 | 1.16 Billion USD | -16.55% |
| 2023 Q4 | 1.4 Billion USD | 13.47% |
| 2023 Q2 | 1.34 Billion USD | 1.04% |
| 2023 Q1 | 1.33 Billion USD | 1.95% |
| 2023 Q3 | 1.23 Billion USD | -8.12% |
| 2023 FY | 4.66 Billion USD | -5.23% |
| 2022 FY | 4.92 Billion USD | 1.1% |
| 2022 Q2 | 1.27 Billion USD | 9.25% |
| 2022 Q1 | 1.16 Billion USD | -6.25% |
| 2022 Q3 | 1.18 Billion USD | -7.02% |
| 2022 Q4 | 1.3 Billion USD | 10.43% |
| 2021 Q2 | 1.44 Billion USD | 8.59% |
| 2021 Q3 | 1.34 Billion USD | -7.11% |
| 2021 Q1 | 1.33 Billion USD | -7.44% |
| 2021 Q4 | 1.24 Billion USD | -7.58% |
| 2021 FY | 4.86 Billion USD | -0.6% |
| 2020 Q3 | 1.35 Billion USD | 69.65% |
| 2020 Q1 | 1.29 Billion USD | -15.99% |
| 2020 Q2 | 801.6 Million USD | -38.18% |
| 2020 Q4 | 1.43 Billion USD | 5.74% |
| 2020 FY | 4.89 Billion USD | -14.55% |
| 2019 FY | 5.72 Billion USD | 1.21% |
| 2019 Q1 | 1.42 Billion USD | -4.4% |
| 2019 Q2 | 1.4 Billion USD | -1.04% |
| 2019 Q3 | 1.35 Billion USD | -3.6% |
| 2019 Q4 | 1.54 Billion USD | 13.77% |
| 2018 Q4 | 1.48 Billion USD | 13.76% |
| 2018 FY | 5.66 Billion USD | -0.53% |
| 2018 Q1 | 1.44 Billion USD | -2.77% |
| 2018 Q2 | 1.42 Billion USD | -1.24% |
| 2018 Q3 | 1.3 Billion USD | -8.16% |
| 2017 Q2 | 1.42 Billion USD | -2.57% |
| 2017 FY | 5.69 Billion USD | 7.2% |
| 2017 Q4 | 1.48 Billion USD | 12.58% |
| 2017 Q3 | 1.31 Billion USD | -7.68% |
| 2017 Q1 | 1.46 Billion USD | 4.73% |
| 2016 Q2 | 1.3 Billion USD | 2.88% |
| 2016 Q3 | 1.35 Billion USD | 3.69% |
| 2016 Q4 | 1.39 Billion USD | 3.3% |
| 2016 FY | 5.3 Billion USD | 28.2% |
| 2016 Q1 | 1.26 Billion USD | 0.36% |
| 2015 Q4 | 1.26 Billion USD | 4.48% |
| 2015 Q1 | 855.7 Million USD | -5.97% |
| 2015 Q3 | 1.21 Billion USD | 37.97% |
| 2015 FY | 4.14 Billion USD | 20.96% |
| 2015 Q2 | 877.1 Million USD | 2.5% |
| 2014 Q4 | 910 Million USD | 12.67% |
| 2014 FY | 3.42 Billion USD | 2.58% |
| 2014 Q3 | 807.7 Million USD | -4.94% |
| 2014 Q2 | 849.7 Million USD | -0.75% |
| 2014 Q1 | 856.1 Million USD | -4.87% |
| 2013 Q2 | 845.9 Million USD | -0.01% |
| 2013 Q1 | 846 Million USD | -4.04% |
| 2013 Q4 | 899.9 Million USD | 20.71% |
| 2013 Q3 | 745.5 Million USD | -11.87% |
| 2013 FY | 3.33 Billion USD | -0.27% |
| 2012 FY | 3.34 Billion USD | 0.5% |
| 2012 Q3 | 769.8 Million USD | -8.69% |
| 2012 Q2 | 843.1 Million USD | -1.04% |
| 2012 Q1 | 852 Million USD | -1.4% |
| 2012 Q4 | 881.6 Million USD | 14.52% |
| 2011 Q1 | 836.6 Million USD | -2.78% |
| 2011 FY | 3.32 Billion USD | 3.8% |
| 2011 Q4 | 864.1 Million USD | 10.84% |
| 2011 Q3 | 779.6 Million USD | -8.23% |
| 2011 Q2 | 849.5 Million USD | 1.54% |
| 2010 Q3 | 745.8 Million USD | -7.6% |
| 2010 Q1 | 794.4 Million USD | -4.62% |
| 2010 Q2 | 807.1 Million USD | 1.6% |
| 2010 FY | 3.2 Billion USD | 3.32% |
| 2010 Q4 | 860.5 Million USD | 15.38% |
| 2009 Q1 | 762.3 Million USD | -3.15% |
| 2009 FY | 3.1 Billion USD | -0.61% |
| 2009 Q4 | 832.9 Million USD | 14.68% |
| 2009 Q3 | 726.3 Million USD | -7.25% |
| 2009 Q2 | 783.1 Million USD | 2.73% |
| 2008 Q1 | 804.5 Million USD | -1.84% |
| 2008 Q2 | 817.2 Million USD | 1.58% |
| 2008 Q4 | 787.1 Million USD | 10.08% |
| 2008 Q3 | 715 Million USD | -12.51% |
| 2008 FY | 3.12 Billion USD | 3.38% |
| 2007 Q2 | 754.2 Million USD | 1.4% |
| 2007 Q3 | 704 Million USD | -6.66% |
| 2007 FY | 3.02 Billion USD | 11.28% |
| 2007 Q1 | 743.8 Million USD | 2.44% |
| 2007 Q4 | 819.6 Million USD | 16.42% |
| 2006 Q4 | 726.1 Million USD | 14.06% |
| 2006 FY | 2.71 Billion USD | 6.62% |
| 2006 Q3 | 636.6 Million USD | -6.6% |
| 2006 Q1 | 671 Million USD | 1.28% |
| 2006 Q2 | 681.6 Million USD | 1.58% |
| 2005 FY | 2.54 Billion USD | 15.71% |
| 2005 Q1 | 638.2 Million USD | 4.33% |
| 2005 Q2 | 658 Million USD | 3.1% |
| 2005 Q3 | 588 Million USD | -10.64% |
| 2005 Q4 | 662.5 Million USD | 12.67% |
| 2004 Q1 | 522.7 Million USD | 9.47% |
| 2004 Q3 | 531.1 Million USD | -0.82% |
| 2004 Q2 | 535.5 Million USD | 2.45% |
| 2004 FY | 2.2 Billion USD | 58.94% |
| 2004 Q4 | 611.7 Million USD | 15.18% |
| 2003 Q2 | 312.7 Million USD | 6.65% |
| 2003 FY | 1.38 Billion USD | 34.76% |
| 2003 Q3 | 301.4 Million USD | -3.61% |
| 2003 Q1 | 293.2 Million USD | 6.04% |
| 2003 Q4 | 477.5 Million USD | 58.43% |
| 2002 Q4 | 276.5 Million USD | 9.55% |
| 2002 FY | 1.02 Billion USD | 20.51% |
| 2002 Q1 | 238.3 Million USD | 4.02% |
| 2002 Q2 | 260.4 Million USD | 9.27% |
| 2002 Q3 | 252.4 Million USD | -3.07% |
| 2001 Q3 | 207.8 Million USD | -1.98% |
| 2001 FY | 852.7 Million USD | 13.74% |
| 2001 Q2 | 212 Million USD | 3.47% |
| 2001 Q1 | 204.9 Million USD | 5.35% |
| 2001 Q4 | 229.1 Million USD | 10.25% |
| 2000 Q2 | 192.4 Million USD | 4.79% |
| 2000 Q1 | 183.6 Million USD | 0.0% |
| 2000 FY | 749.7 Million USD | 11.9% |
| 2000 Q4 | 194.5 Million USD | 8.36% |
| 2000 Q3 | 179.5 Million USD | -6.7% |
| 1999 FY | 670 Million USD | 12.42% |
| 1998 FY | 596 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Abbott Laboratories | 22.13 Billion USD | 76.008% |
| Allurion Technologies Inc. | 41.49 Million USD | -12697.07% |
| Artivion, Inc. | 229.17 Million USD | -2217.171% |
| Avanos Medical, Inc. | 379.7 Million USD | -1298.578% |
| Butterfly Network, Inc. | 16.85 Million USD | -31404.509% |
| Butterfly Network, Inc. | 16.85 Million USD | -31404.509% |
| Bio-Rad Laboratories, Inc. | 1.43 Billion USD | -271.007% |
| Boston Scientific Corporation | 9.89 Billion USD | 46.332% |
| Perspective Therapeutics, Inc. | 1.63 Million USD | -324893.88% |
| CONMED Corporation | 643.06 Million USD | -725.793% |
| Edwards Lifesciences Corporation | 4.62 Billion USD | -14.819% |
| Paragon 28, Inc. | 172.79 Million USD | -2973.308% |
| Glaukos Corporation | 239.13 Million USD | -2120.661% |
| Globus Medical, Inc. | 1.02 Billion USD | -420.473% |
| Inspire Medical Systems, Inc. | 528.22 Million USD | -905.333% |
| Integer Holdings Corporation | 418.28 Million USD | -1169.553% |
| Medtronic plc | 19.45 Billion USD | 72.701% |
| Nevro Corp. | 290.06 Million USD | -1730.794% |
| Owlet, Inc. | 22.58 Million USD | -23410.869% |
| Penumbra, Inc. | 682.64 Million USD | -677.918% |
| Vicarious Surgical Inc. | -1.85 Million USD | 286529.342% |
| Smith & Nephew plc | 3.7 Billion USD | -43.486% |
| Sonendo, Inc. | 10.72 Million USD | -49428.073% |
| STERIS plc | 2.23 Billion USD | -137.709% |
| Stryker Corporation | 13.05 Billion USD | 59.332% |
| Vapotherm, Inc. | 28.28 Million USD | -18675.943% |